Clinical Trials Browser

Phase 2 × Leukemia, Promyelocytic, Acute × Erlotinib Hydrochloride × Clear all

NCT01664897 2020-01-07

Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute